Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection.
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients.
Orthopaedic Management of Spasticity.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.
Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation.
Acrolein-mediated conduction loss is partially restored by potassium channel blockers.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
Reglan: No Prescription Us Pharmacy
Options in improving respiratory function in multiple sclerosis.
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
Mining gene expression data of multiple sclerosis.
Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
Developing and implementing lifestyle management programs© with people with multiple sclerosis.
Standing Data Disproves Biomechanical Mechanism for Balance-Based Torso-Weighting.
Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple Sclerosis.
Anti-Interferon Beta Antibody Titers Strongly Correlate Between Two Bioassays and In Vivo Biomarker Expression, and Indicates That a Titer of 150 TRU/mL Is a Biologically Functional Cut-Point.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Vaccination, infection, and the risk for multiple sclerosis.
Comparative Effects of Human Neural Stem Cells and Oligodendrocyte Progenitor Cells on the Neurobehavioral Disorders of Experimental Autoimmune Encephalomyelitis Mice.
Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants.
Pages
« first
‹ previous
…
547
548
549
550
551
552
553
554
555
…
next ›
last »